ArticleJournal of translational medicine2026
A novel therapeutic monoclonal antibody targeting PZR demonstrates potent anti-metastatic efficacy in triple-negative breast cancer.
Jiayu Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.